Sana Biotechnology Inc Ordinary Shares SANA

Morningstar Rating
$1.85 −0.03 (1.60%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SANA is trading at a LOCK|!hBnft premium.
Price
$1.89
Fair Value
LOCK|RD<<mrt
Uncertainty
LOCK|&< >#>X
1-Star Price
LOCK|s@S#V!
5-Star Price
LOCK|TlG?Hf
Economic Moat
LOCK|p<
Capital Allocation
—

News

Trading Information

Previous Close Price
$1.88
Day Range
$1.84–2.00
52-Week Range
$1.84–5.49
Bid/Ask
$1.86 / $1.91
Shares Outstanding
299.63M
Market Cap
$554.32M
Volume/Avg
3M / 3M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
—
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
142

Valuation

Metric
SANA
Price/Earnings (Normalized)
—
Price/Book Value
3.12
Price/Sales
—
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
SANA
Quick Ratio
1.63
Current Ratio
1.77
Interest Coverage
—
Quick Ratio
SANA

Profitability

Metric
SANA
Return on Assets (Normalized)
−40.87%
Return on Equity (Normalized)
−102.55%
Return on Invested Capital (Normalized)
−72.71%
Return on Assets
SANA

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|<GpRMsGLOCK|P?y&$135B
Regeneron Pharmaceuticals Inc
REGN
LOCK|H#fPH>LOCK|$xr&K$99B
Moderna Inc
MRNA
LOCK|y&XslH<LOCK|JC$84B
argenx SE ADR
ARGX
LOCK|!n<T%<LOCK|Z>!$59B
BeOne Medicines Ltd ADR
ONC
LOCK|r%%%gL!LOCK|S<w$48B
Royalty Pharma PLC Class A
RPRX
LOCK|sPTzN^g%LOCK|P!Ys$31B
Incyte Corp
INCY
LOCK|V<b>bzLOCK|%m>$24B
BioNTech SE ADR
BNTX
LOCK|Hg!@@W>LOCK|J$v$21B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|?<fS>$LOCK|qm>^L$21B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|FV$dW^<LOCK|gTt$15B

Sponsor Center